Bio-Rad Laboratories Inc

BUW

Company Profile

  • Business description

    Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

  • Contact

    1000 Alfred Nobel Drive
    HerculesCA94547
    USA

    T: +1 510 724-7000

    E: [email protected]

    https://www.bio-rad.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    7,450

Stocks News & Analysis

stocks

ASX biotech expands diagnostics portfolio after FDA approval

FDA nod adds another growth driver for ASX share.
stocks

Is it time to bail on Australian stocks?

Is your home bias costing your portfolio better returns?
stocks

ASX share undervalued despite margin woes

Short term margin pressure yet shares remain undervalued on improved outlook.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,874.5025.200.28%
CAC 408,103.4413.160.16%
DAX 4025,425.4623.180.09%
Dow JONES (US)52,093.11328.09-0.63%
FTSE 10010,691.5233.390.31%
HKSE24,713.7846.540.19%
NASDAQ25,981.57204.84-0.78%
Nikkei 22563,923.00438.900.69%
NZX 50 Index13,622.72138.501.03%
S&P 5007,585.7334.25-0.45%
S&P/ASX 2008,696.5024.000.28%
SSE Composite Index3,891.6027.320.71%

Market Movers